Literature DB >> 8264569

Effect of statil on kidney structure, function and polyol accumulation in diabetes mellitus.

G Faiman1, P Ganguly, A Mehta, J A Thliveris.   

Abstract

We examined the effects of an aldose-reductase inhibitor, statil, which blocks the conversion of glucose to sorbitol, in rats rendered diabetic with streptozotocin in order to determine whether the anticipated changes in sorbitol content was associated with beneficial lack of changes in renal morphology and function. Groups of diabetic, insulin-treated and untreated rats were fed statil daily for a period of five months; each group was paired with a non-drug-treatment control group. At the conclusion of the study period, statil was not found to affect renal sorbitol concentrations nor did it effect functional or structural changes seen in the kidney. We conclude that further study, using other doses of statil and longer duration over which data is collected, must be undertaken in order to implicate the polyol pathway in the renal complications of diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8264569     DOI: 10.1007/bf00926831

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  24 in total

Review 1.  Mechanisms initiating cataract formation. Proctor Lecture.

Authors:  J H Kinoshita
Journal:  Invest Ophthalmol       Date:  1974-10

2.  Evaluation of an affinity chromatographic procedure for the determination of glycosylated hemoglobin (HbA1).

Authors:  R W Yatscoff; G J Tevaarwerk; C L Clarson; L M Warnock
Journal:  Clin Biochem       Date:  1983-10       Impact factor: 3.281

3.  Reversal, by treatment with an aldose reductase inhibitor, of impaired axonal transport and motor nerve conduction velocity in experimental diabetes mellitus.

Authors:  D R Tomlinson; P R Holmes; J H Mayer
Journal:  Neurosci Lett       Date:  1982-08-16       Impact factor: 3.046

4.  The localisation of sorbitol pathway activity in the rat renal cortex and its relationship to the pathogenesis of the renal complications of diabetes mellitus.

Authors:  J C Hutton; P J Schofield; J F Williams; F C Hollows
Journal:  Aust J Exp Biol Med Sci       Date:  1975-02

5.  Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil.

Authors:  A Beyer-Mears; L Ku; M P Cohen
Journal:  Diabetes       Date:  1984-06       Impact factor: 9.461

6.  Sorbinil does not prevent hyperfiltration, elevated ultrafiltration pressure and albuminuria in streptozotocin-diabetic rats.

Authors:  A Körner; G Celsi; A C Eklöf; T Linné; B Persson; A Aperia
Journal:  Diabetologia       Date:  1992-05       Impact factor: 10.122

7.  Kidney complications.

Authors:  D M Brown; G A Andres; T H Hostetter; S M Mauer; R Price; M A Venkatachalam
Journal:  Diabetes       Date:  1982       Impact factor: 9.461

8.  Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study.

Authors:  A R Andersen; J S Christiansen; J K Andersen; S Kreiner; T Deckert
Journal:  Diabetologia       Date:  1983-12       Impact factor: 10.122

9.  Altering the course of cataracts in diabetic rats.

Authors:  S Fukushi; L O Merola; J H Kinoshita
Journal:  Invest Ophthalmol Vis Sci       Date:  1980-03       Impact factor: 4.799

10.  Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats.

Authors:  R E Schmidt; S B Plurad; W R Sherman; J R Williamson; R G Tilton
Journal:  Diabetes       Date:  1989-05       Impact factor: 9.461

View more
  2 in total

Review 1.  Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Authors:  T Baba; S Neugebauer; T Watanabe
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

2.  Genetic deficiency of aldose reductase counteracts the development of diabetic nephropathy in C57BL/6 mice.

Authors:  H Liu; Y Luo; T Zhang; Y Zhang; Q Wu; L Yuan; S S M Chung; P J Oates; J Y Yang
Journal:  Diabetologia       Date:  2011-01-27       Impact factor: 10.122

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.